• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 h: a retrospective cohort study

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Dec 12;13(1):22054.
doi: 10.1038/s41598-023-49340-6. Characteristics of patients with COVID-19 who have deteriorating chest X-ray findings within 48 h: a retrospective cohort study

Tatsuya Kusumoto[SUP] 1 [/SUP], Shotaro Chubachi[SUP] 2 [/SUP], Ho Namkoong[SUP] 3 [/SUP], Hiromu Tanaka[SUP] 1 [/SUP], Ho Lee[SUP] 1 [/SUP], Shiro Otake[SUP] 1 [/SUP], Kensuke Nakagawara[SUP] 1 [/SUP], Takahiro Fukushima[SUP] 1 [/SUP], Atsuho Morita[SUP] 1 [/SUP], Mayuko Watase[SUP] 4 [/SUP], Takanori Asakura[SUP] 5 [/SUP], Katsunori Masaki[SUP] 1 [/SUP], Hirofumi Kamata[SUP] 1 [/SUP], Makoto Ishii[SUP] 1 [/SUP], Naoki Hasegawa[SUP] 6 [/SUP], Norihiro Harada[SUP] 7 [/SUP], Tetsuya Ueda[SUP] 8 [/SUP], Soichiro Ueda[SUP] 9 [/SUP], Takashi Ishiguro[SUP] 10 [/SUP], Ken Arimura[SUP] 11 [/SUP], Fukuki Saito[SUP] 12 [/SUP], Takashi Yoshiyama[SUP] 13 [/SUP], Yasushi Nakano[SUP] 14 [/SUP], Yoshikazu Mutoh[SUP] 15 [/SUP], Yusuke Suzuki[SUP] 16 [/SUP], Ryuya Edahiro[SUP] 17 [/SUP], Koji Murakami[SUP] 18 [/SUP], Yasunori Sato[SUP] 19 [/SUP], Yukinori Okada[SUP] 17 20 21 22 [/SUP], Ryuji Koike[SUP] 23 [/SUP], Yuko Kitagawa[SUP] 24 [/SUP], Katsushi Tokunaga[SUP] 25 [/SUP], Akinori Kimura[SUP] 26 [/SUP], Seiya Imoto[SUP] 27 [/SUP], Satoru Miyano[SUP] 28 [/SUP], Seishi Ogawa[SUP] 29 30 31 [/SUP], Takanori Kanai[SUP] 32 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP]



Affiliations
Abstract

The severity of chest X-ray (CXR) findings is a prognostic factor in patients with coronavirus disease 2019 (COVID-19). We investigated the clinical and genetic characteristics and prognosis of patients with worsening CXR findings during early hospitalization. We retrospectively included 1656 consecutive Japanese patients with COVID-19 recruited through the Japan COVID-19 Task Force. Rapid deterioration of CXR findings was defined as increased pulmonary infiltrates in ≥ 50% of the lung fields within 48 h of admission. Rapid deterioration of CXR findings was an independent risk factor for death, most severe illness, tracheal intubation, and intensive care unit admission. The presence of consolidation on CXR, comorbid cardiovascular and chronic obstructive pulmonary diseases, high body temperature, and increased serum aspartate aminotransferase, potassium, and C-reactive protein levels were independent risk factors for rapid deterioration of CXR findings. Risk variant at the ABO locus (rs529565-C) was associated with rapid deterioration of CXR findings in all patients. This study revealed the clinical features, genetic features, and risk factors associated with rapid deterioration of CXR findings, a poor prognostic factor in patients with COVID-19.


 
Back
Top Bottom